Zhu Xinyun, Yang Lijie, Li Xianglei, Zhu Fengya, Li Zimeng, Craemer Andrea, Xiong Yueheng, Lan Ying, Zhao Yuemeng, Wu Jie
Acupuncture and Moxibustion School, Chengdu University of Traditional Chinese Medicine.
Hospital of Chengdu University of Traditional Chinese Medicine, Jinniu District, Chengdu, Sichuan.
Medicine (Baltimore). 2020 Feb;99(8):e19044. doi: 10.1097/MD.0000000000019044.
The purpose of this study is to evaluate the efficacy and safety of acupuncture on relieving abdominal pain and distension in acute pancreatitis.
We will electronically search PubMed, MEDLINE, Embase, Web of Science, the Cochrane Central Register of Controlled Trial, China National Knowledge Infrastructure, China Biomedical Literature Database, China Science Journal Database, and Wanfang Database from their inception. Furthermore, we will manually retrieve other resources, including reference lists of identified publications, conference articles, and gray literature. The clinical randomized controlled trials or quasi-randomized controlled trials related to acupuncture treating acute pancreatitis will be included in the study. The language is limited to Chinese and English. Research selection, data extraction, and research quality assessment will be independently completed by 2 researchers. Data will be synthesized using a fixed effects model or random effects model depending on the heterogeneity test. The overall response rate and the visual analog scale score will be the primary outcomes. The time of first bowel sound, the time of first defecation, the length of hospitalization, acute physiology and chronic health evaluation II score, and the adverse events will also be assessed as secondary outcomes. RevMan 5 (version 5.3) statistical software will be used for meta-analysis, and the level of evidence will be assessed by Grading of Recommendations Assessment, Development, and Evaluation. Continuous data will be expressed in the form of weighted mean difference or standardized mean difference with 95% confidence intervals, whereas dichotomous data will be expressed in the form of risk ratios with 95% confidence intervals.
The protocol of this systematic review does not require ethical approval because it does not involve humans. We will publish this article in peer-reviewed journals and present at relevant conferences.
CRD42019147503.
本研究旨在评估针刺缓解急性胰腺炎腹痛腹胀的疗效和安全性。
我们将从数据库建立起,通过电子检索PubMed、MEDLINE、Embase、Web of Science、Cochrane对照试验中心注册库、中国知网、中国生物医学文献数据库、中国科学期刊数据库和万方数据库。此外,我们还将手动检索其他资源,包括已识别出版物的参考文献列表、会议文章和灰色文献。纳入研究的将是与针刺治疗急性胰腺炎相关的临床随机对照试验或半随机对照试验。语言限于中文和英文。研究筛选、数据提取和研究质量评估将由2名研究人员独立完成。根据异质性检验,数据将使用固定效应模型或随机效应模型进行综合分析。总有效率和视觉模拟量表评分将作为主要结局指标。首次肠鸣音时间、首次排便时间、住院时间、急性生理与慢性健康状况评分II以及不良事件也将作为次要结局指标进行评估。将使用RevMan 5(5.3版)统计软件进行荟萃分析,并通过推荐分级的评估、制定和评价来评估证据水平。连续数据将以加权均数差或标准化均数差的形式表示,并带有95%置信区间,而二分数据将以风险比的形式表示,并带有95%置信区间。
本系统评价方案不需要伦理批准,因为它不涉及人类。我们将在同行评审期刊上发表本文,并在相关会议上展示。
PROSPERO注册号:CRD42019147503。